Cadrenal Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $2 | $0 |
Gross Profit | -5 | 1 | ||
EBITDA | -3,734 | -3,839 | -4,186 | -2,407 |
EBIT | -3,734 | -3,845 | -4,187 | -2,407 |
Net Income | -3,667 | -3,845 | -4,187 | -2,407 |
Net Change In Cash | 0 | 0 | 2 | 0 |
Free Cash Flow | -3,022 | -4,652 | -1,797 | -2,201 |
Cash | 5,570 | 7,336 | 10,017 | 4,363 |
Basic Shares | 1,961 | 1,844 | 1,525 | 1,104 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -1 | -1 |
EBITDA | -10,649 | -8,338 |
EBIT | -10,651 | -8,339 |
Net Income | -10,651 | -8,357 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -7,364 | -3,533 |
Cash | 10,017 | 8,402 |
Basic Shares | 1,219 | 868 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$1.87 |
2025-03-31 | -$2.09 |
2024-12-31 | -$2.55 |
